Clinical Trial Update: Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis [Phase 2]

View source ↗

Summary

Phase 2 trial update on BCD-180 assessing efficacy, safety, PK and PD in axial spondyloarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• BCD-180

Snippet

Sponsor: Biocad | Conditions: Axial Spondyloarthritis | Phase 2 | Status: ACTIVE_NOT_RECRUITING